| 000 | 01531 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518054809.0 | ||
| 264 | 0 | _c20200309 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0218759 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKwo, Paul Y | |
| 245 | 0 | 0 |
_aInitial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis. _h[electronic resource] |
| 260 |
_bPloS one _c2019 |
||
| 300 |
_ae0218759 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndiana |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 650 | 0 | 4 | _aTime-to-Treatment |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aPuenpatom, Amy | |
| 700 | 1 | _aZhang, Zuoyi | |
| 700 | 1 | _aHui, Siu L | |
| 700 | 1 | _aKelley, Andrea A | |
| 700 | 1 | _aMuschi, David | |
| 773 | 0 |
_tPloS one _gvol. 14 _gno. 8 _gp. e0218759 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0218759 _zAvailable from publisher's website |
| 999 |
_c30029477 _d30029477 |
||